Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.27 - $3.0 $86,523 - $114,348
-38,116 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$2.45 - $4.1 $8,533 - $14,280
-3,483 Reduced 8.37%
38,116 $116,000
Q2 2021

Aug 16, 2021

SELL
$3.0 - $4.39 $257,142 - $376,284
-85,714 Reduced 67.33%
41,599 $162,000
Q1 2021

May 17, 2021

BUY
$2.2 - $5.05 $280,088 - $642,930
127,313 New
127,313 $456,000

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $103M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.